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ABSTRACT
PURPOSE: Although previous studies suggest that orthokeratology 
contact lens wear slows eye growth in children with progressing 
myopia, some limitations in the methodology employed have 
become evident. Furthermore, the safety of this modality of visual 
correction has not been assessed. The study “Myopia Control with 
Orthokeratology Contact Lenses in Spain” (MCOS) is being con-
ducted to compare axial length growth between white European 
myopic children wearing orthokeratology contact lenses (OK) and 
wearing distance single-vision spectacles (SV). Additionally, the 
incidence of adverse events and discontinuations is also recorded. 
We outline the methodology and baseline data adopted.
METHODS: Subjects aged 6 to 12, with myopia ranging from 0.75 to 
4.00 D and astigmatism ≤1.00 D were prospectively allocated OK 
or SV correction. Measurements of axial length, anterior chamber 
depth, corneal topography, cycloplegic autorefraction, visual acuity 
and corneal staining are performed at 6-month intervals. The inci-
dence of adverse events and discontinuations are also recorded. 
RESULTS: Thirty one children were fitted with OK and 31 with SV 
correction. Eight subjects did not meet the refraction-related inclu-
sion criteria for enrollment. No significant differences were found 
in baseline mean age and refractive and biometric data between the 
two groups (P>0.05). No adverse events were found in any of the 
two groups at baseline.
CONCLUSION: To the authors’ knowledge, MCOS is the first pros-
pective clinical trial to assess the safety and efficacy of orthokerato-
logy contact lens wear to slow myopia progression vs. single-vision 
spectacle wear. The MCOS offers a number of notable features: 
prospective design; well-matched samples and high-resolution ocu-
lar biometry measures, which should collectively elucidate whether 
orthokeratology contact lens wear is a feasible and safe method for 
myopia-progression control.
(J Optom 2009;2:215-222 ©2009 Spanish Council of Optometry)
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progression; eye elongation.
RESUMEN
OBJETIVO: A pesar de que estudios previos sugieren que el uso de 
lentes de contacto para ortoqueratología ralentizan el crecimiento 
ocular en niños con miopía progresiva, ha quedado de manifiesto 
algunas limitaciones en la metodología empleada en dichos estu-
dios. Además, hasta la fecha no se ha evaluado la seguridad de esta 
modalidad de corrección visual. El estudio “Control de la miopía 
con lentes de contacto para ortoqueratología en España” (MCOS, 
según sus siglas en inglés) se está llevando a cabo para evaluar el 
aumento de la longitud axial ocular en niños miopes europeos de 
raza blanca, usuarios de lentes de contacto de ortoqueratología 
frente a usuarios de gafas monofocales. Además, también se está 
evaluando la incidencia de reacciones adversas y abandonos. En este 
artículo explicamos la metodología empleada, así como los datos 
iniciales del estudio. 
MÉTODOS: Se asignó de manera prospectiva corrección OK o SV a 
sujetos de entre 6 y 12 años de edad, con una miopía comprendida 
entre  0,75 y 4,00 D y con astigmatismo ≤1,00 D. Se llevan a cabo, 
inicialmente y cada 6 meses, medidas de la longitud axial, profun-
didad de la cámara anterior, topografía corneal, de autorrefracción 
cicloplégica, agudeza visual y tinción corneal. Además, se está eva-
luando la incidencia de reacciones adversas y abandonos. 
RESULTADOS: A 31 niños se les adaptó corrección OK y a 30 correc-
ción SV. Ocho sujetos no cumplían el criterio de inclusión relativo 
a la refracción. No se encontraron diferencias significativas entre los 
dos grupos en lo que respecta a edad media y a valores de refractivos 
y biométricos (P>0.05). No se encontraron reacciones adversas en 
ninguno de los 2 grupos en la visita inicial.
CONCLUSIONES: Según el conocimiento de los autores, el MCOS es 
el primer ensayo clínico prospectivo en el que se evalúa la seguridad 
y eficacia del uso de lentes de contacto ortoqueratológicas para 
ralentizar el avance de la miopía, comparando los resultados con 
los obtenidos en un grupo de control compuesto por usuarios de 
gafas monofocales para miopía. El estudio MCOS tiene una serie de 
características destacables: diseño prospectivo; muestras bien empa-
rejadas, medidas de biometría ocular de alta resolución; todo ello 
debería permitir dilucidar si el uso de lentes de contacto ortoquera-
tológicas es un método factible y eficaz para frenar la progresión de 
la miopía en niños.
(J Optom 2009;2:215-222 ©2009 Consejo General de Colegios de 
Ópticos-Optometristas de España)
PALABRAS CLAVE:  control de la miopía; ortoqueratología; longitud 
axial; progresión de la miopía; elongación ocular.
INTRODUCTION
The prevalence of myopia in young adolescents has increa-
sed substantially over recent decades and is now approaching 
10-25% and 60-80% in industrialized societies of Western 
and Eastern Asia, respectively;1 worldwide, the condition is 
considered to be the leading cause of visual impairment.2 In 
clinical terms, it is widely acknowledged that the myopic eye 
is a vulnerable eye, especially for myopia levels greater than 
6.00 D, and one that is especially susceptible to a range of 
ocular pathologies.3-7 Several treatment therapies, including 
rigid contact lenses, bifocal and multifocal spectacle lenses 
as well as pharmaceutical agents, have been used in the past 
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  with relatively modest success to eliminate or, at least, reduce 
myopia progression.8,9 More recently, modern orthokeratolo-
gy has claimed to be effective in slowing the progression of 
myopia in children. This technique is an effective treatment 
for the temporary reduction of up to -6.00D of myopia with 
the overnight use of reverse-geometry gas-permeable contact 
lenses.10 Usually, studies evaluating the effect of orthokerato-
logy lens wear on myopia progression measure changes in the 
eye’s axial length, the principal structural correlate of refrac-
tive error,11 due to the concomitant temporary reduction in 
myopia that occurs as a consequence of the corneal flattening 
induced by orthokeratology contact lens wear.12  
Although a retrospective study13 and a case report14 on 
the subject were previously published, only two prospective 
studies have assessed the effect of orthokeratology contact 
lens wear on myopia progression in children.15,16 
 Over a two-year period, Cho et al.15 monitored the 
increase in axial length in 35 Hong-Kong Chinese children 
aged 7 to 12 who were fitted with orthokeratology lenses, 
and compared the rate of change of axial length with that 
observed in a historical control group made up of 35 children 
wearing single-vision spectacles. Both groups were matched 
for age, gender and baseline spherical equivalent refractive 
error. At the end of the 24 months, the increase in axial leng-
th was 0.29±0.27 mm and 0.54±0.27 mm for the orthokera-
tology lenses and single-vision spectacle groups, respectively. 
However, the study failed to recruit a prospective control 
group. Furthermore, the baseline level and progression of 
myopia observed among Chinese children are reported to be 
significantly greater than among white European children.8 
In addition, differences in contact-lens-induced responses in 
the corneas of Asian and non-Asian subjects have also been 
previously observed.17 
More recently, a study undertaken in the USA by Walline 
and co-workers16 compared the growth of the eye observed 
among myopic children wearing orthokeratology contact 
lenses with that observed in a historical control group of 
children wearing soft contact lenses. The groups consisted 
of children aged 8 to 11 with myopia ranging from 0.75 to 
4.00 D and having less than  1.00 D of astigmatism. Over 
the two-year period, the axial length for the soft-contact-lens 
group increased, on average, 0.32 mm more than for the 
orthokeratology-lens group. However, the Walline et al.16 
study was unable to recruit a prospective control group. Since 
Cho et al.15 and Walline et al.16 employed historical pros-
pective control groups, subjects were not randomized into 
one modality of visual correction vs. another. Additionally, 
these two previous studies measured axial-length growth 
using A-scan ultrasonography.15,16 An alternative measuring 
method (the Zeiss IOLMaster) uses partial coherence inter-
ferometry to carry out non-contact measures of axial length 
with a dioptric resolution of 0.03 D (an order of magnitude 
better than the 10 Hz ultrasound technique).18
As with any treatment regimen, both efficacy and safety 
need to be assessed. Although case reports and case series of 
observations on undefined populations of participants wea-
ring overnight orthokeratology contact lenses have been pre-
sented, there are no formal prospective reports on the inci-
dence of adverse events associated with overnight orthokera-
tology contact lenses specifically used to treat myopia.19  
This report introduces the study designated as MCOS 
(Myopia Control with Orthokeratology contact lenses in Spain) 
and outlines its design, methodology and baseline findings. The 
primary outcome measure of MCOS is to compare differences 
in axial length growth between white European myopic chil-
dren wearing orthokeratology contact lenses (OK) and distance 
single-vision spectacles (SV) over a 2 year period. The secondary 
outcome is to record differences in the incidence of adverse 
events and discontinuations between the two study groups. To 
the authors’ knowledge, the MCOS study is the first prospec-
tive clinical trial to assess the safety and efficacy of overnight 
orthokeratology contact lens wear. 
METHODS
Sample size
The study’s sample size was calculated using a statistical 
power analysis software (JMPIN 4.0.2, SAS Institute Inc., 
NC, USA) based on data from previous clinical trials.15,16 
Assuming that the standard deviation of the change in axial 
length over a two-year period is 0.27 mm and taking a statis-
tical power of 0.90, a sample size of 25 subjects per group is 
needed to be able to detect a difference of variation in axial 
length equal to 0.25 mm (equivalent to approximately 0.75 
D)20 at P=0.05. Previous studies have reported drop-out rates 
of approximately 17% among OK15 and SV21 subjects enro-
lled in clinical trials. Therefore, to account for attrition, the 
number of subjects to be recruited in this study was taken to 
be at least 29 per group. 
Method of Recruitment
Subjects were sought through advertisements in local 
newspapers, among individuals attending the clinic where 
the study was to be undertaken, by word-of-mouth and by 
randomly mailing the area of Madrid. 
Recruitment Session and Follow-up Visits
The objectives of the recruitment session were to determi-
ne whether or not the children met the inclusion and exclu-
sion criteria for the study (Table 1) and to inform the child’s 
parent(s) or guardian(s) verbally and in writing about the natu-
re of the study. During this session, parent(s) or guardian(s) 
were given a balanced account of the advantages and disad-
vantages of the two vision correction modalities offered in the 
study (i.e. SV or OK). Particular care was taken not to suggest 
that one modality might perform better than the other or 
provide a better control over myopia progression. Parent(s) or 
guardian(s) were also informed that for the whole duration of 
the study (2 years) children would obtain visual correction (i.e. 
glasses or contact lenses) made to their prescription, contact 
lens care solutions (for the OK group only) and full ocular exa-
minations free of charge. After parent(s) or guardian(s) chose 
one of the two modalities offered, full informed consent and 
child assent were obtained prior to the start of all experimental 
work and data collection. The informed consent also included 
detailed information regarding the potential adverse reactions 
that might occur as a result of contact lens wear (e.g. microbial 
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keratitis). Patient participation in the study could be disconti-
nued at the examiner’s discretion should significant symptoms 
or slit-lamp findings occur. Subjects were instructed that they 
could withdraw from the study anytime. All measurements 
were obtained at Clinica Oftalmológica Novovision (Madrid, 
Spain). The study protocol was reviewed and approved by the 
Institutional Review Board. No Ethics Committee Aproval 
was required; otherwise, the study followed the tenets of the 
Declaration of Helsinki.
At the recruitment session, all subjects underwent a full 
anterior segment examination, indirect fundus microsco-
py, binocular vision and refractive evaluations to elucidate 
whether or not they were eligible to participate in the study. 
Subsequently, baseline study measurements were performed 
in eligible subjects (see below for further details on the mea-
surement procedures). 
Subjects in the SV group were prescribed distance single-
vision spectacles having the highest positive power consistent 
with optimum visual acuity and were asked to wear the spec-
tacles at all times. Subjects in the OK group were fitted with 
Menicon Z Night contact lenses (Table 2) using the Menicon 
Professional Easy Fit Software (Figure 1) (Menicon Co., Ltd, 
Nagoya, Japan). Corneal topography and cycloplegic refrac-
tion data for both eyes of each subject were input into the 
software, which automatically calculated the specifications 
of the Menicon Z Night trial lens to allow orthokeratology 
fitting. Contact lenses were ordered and subjects from the OK 
group were rescheduled for an appointment approximately 
two weeks later. After the initial contact lens fitting, on the first 
day all contact lens subjects were instructed in the procedures 
for contact lens insertion, removal and cleaning/disinfection 
and these instructions were reinforced in subsequent visits. 
Subjects were provided with MeniCare Plus multipurpose 
solution for daily cleaning, rinsing and disinfecting of their 
contact lenses, and also Menicon Progent intensive cleaner, to 
be used once a week (Menicon Co., Ltd, Nagoya, Japan). 
Subjects in the OK study group were informed that 
contact lenses had to be inserted every day, just before going 
to sleep, and removed the following morning. Subjects were 
requested to attend no later than two hours after lens removal 
on the morning following the first night of lens wear. A sub-
sequent visit was scheduled for three weeks later to ascertain 
whether or not the contact lens fitting was clinically accepta-
ble; otherwise, new contact lenses were calculated and ordered. 
An orthokeratology fit was considered to be successful if after 
three weeks of lens wear, the subject showed a CCLRU score 
regarding the anterior eye segment signs ≤1 unit,22 a “bull’s 
eye” corneal topography pattern and monocular and binocular 
visual acuities within ±1 line of the best-correct decimal spec-
tacle visual acuity. Subjective over-refraction was undertaken 
to ascertain whether changes in the contact lens base curve 
were required. If so, new lenses were ordered for the subjects 
while maintaining the same  design specifications for the con-
TABLE 1 
Inclusion and exclusion criteria  
Inclusion criteria Exclusion criteria
Be 6 to 12 years of age, both ages inclusive 
A low-to-moderate level of refractive error  
(between  0.75 and  4.00 D) and of astigmatism (≤ 1.00 D)
Neophyte contact lens wearer
Be successfully fitted with spectacles or orthokeratology  
contact lenses
Be able to achieve, through spherical refraction correction,  
a logMAR visual acuity of 0.8 or better in each eye
Be willing and able to follow the subject instructions and  
to meet the protocol-specified schedule of follow-up visits
White European ethnicity
Systemic or ocular disease affecting ocular health
Use of any systemic or topical medications that could affect ocular 
physiology or contact lens performance
Any lid or anterior segment abnormalities for which contact lens 
wear could be contraindicated 
CCLRU grade ≥ 2 for any given anterior segment ocular clinical 
signs 
Aphakic, amblyopic, and atopic individuals 
Refractive astigmatism ≥ ½ spherical refraction
Previous contact lens wear
TABLE 2 
Menicon Z Night contact lens specifications  
Name Menicon Z Night
Manufacturer Menicon
Material name Siloxanylstyrene fluoromethacrylate 
 (tisifilcon A)
Design Parallel reverse geometry
Dk (Barrer) 163
BOZR (mm) 7.20 to 9.50 (0.05 mm steps)
Optic zone diameter (mm) 6
Total diameter (mm) 10.20/10.60 (standard)/11.00
Tangential angle (degrees) 50 to 65 (1º steps)
Sagittal depth (mm) 0.50 to 0.99 (0.01 mm steps)
Wearing modality  Overnight orthokeratology
Replacement 1 year
D: diopters; CCLRU: Cornea and Contact Lens Research Unit.
Dk: oxygen permeability; BOZR: back optic zone radius.
J Optom, Vol. 2, No. 4, October-December 2009
218   Myopia Control with Orthokeratology Contact Lenses in Spain (MCOS): Santodomingo-Rubido J et al.
  
tact len's back surface. In the event of an unsuccessful fitting 
(i.e. flat- or steep-fitting lenses), the Menicon Professional Easy 
Fit Software was used to calculate alternative contact lenses 
that would constitute a successful lens fit; this tool is included 
in the Menicon software. 
It was made clear to all OK subjects that they had to 
remove their contact lenses if they experienced any sort of 
problem. Subjects and their parent/guardians were instructed 
in the steps to take in the event of an adverse reaction, and 
were instructed to ensure adherence to the study protocol. 
Moreover, compliance was monitored closely by one of 
the authors (CV-C). Subjects from both study groups were 
advised to report/turn up at the clinic immediately should 
events not considered normal (e.g. red eye, pain, unusual 
discomfort, unusual eye secretions) occurred.  
After initial enrolment, subjects are seen again at the 
scheduled 1-, 6-, 12-, 18- and 24–months follow-up visits. 
To prevent subjects from forgetting their follow-up appo-
intments, all subjects receive a telephone reminder one day 
before their appointment. Follow-up visits are scheduled to 
fall within two hours of awakening. A decrease in one line of 
visual acuity accompanied by a change in subjective refrac-
tion23 at any one of the follow-up visits was considered to 
be clinically significant and was remedied by supplying new 
contact lenses or spectacles made to their new prescription.
Measurements
Cycloplegic auto-refraction. Three drops of chlorhydrate 
cyclopentolate 1% (Alcon Cusí, Masnou, Barcelona, Spain) 
were instilled 10 minutes apart in each of the subjects’ eyes 
using a multidose bottle. Ten minutes after instillation of the 
third drop, three auto-refraction measurements were taken 
(Topcon RM 8000B, CA, USA) and their mean was calcu-
lated. Additionally, distance subjective refraction was also 
performed before and after cycloplegia. 
Corneal Topography. Corneal topography measurements 
were performed with the Wavelight Allegro Topolyzer 
(WaveLight Laser Technologies AG, Erlangen, Germany). 
The first measurement taken in each eye, which provided 
an optimum index value according to the manufacturer’s 
recommendations, was used for the study. Furthermore, 
the measurement generated a simulated central keratometry 
reading as well as the rate of peripheral corneal flattening/
steepening with displacement from the corneal apex, the lat-
ter indicating the degree to which an aspheric surface differs 
from the spherical form (i.e. e-value).24 
 
Axial Length, Anterior Chamber Depth and Posterior 
Segment Depth Measurements. Measurements of axial length 
and anterior chamber depth were performed with the Zeiss 
IOLMaster (Carl Zeiss Jena GmbH, Jena, Germany).18 Three 
separate measurements of axial length are recorded, whereas a 
single shot automatically recorded five measures of the anterior 
chamber depth. The posterior segment depth was calculated by 
subtracting the anterior chanber depth from the axial length 
obtained with the IOL Master. All biometric measurements 
were undertaken prior to cycloplegia. 
Corneal Staining. The extent and depth of corneal staining 
were measured to the nearest 0.5 unit using the CCLRU 
grading scales.22 Additionally, the location (i.e. superior, 
inferior, nasal, temporal and central) of the staining was also 
recorded. 
Subjective Questionnaires. The Pediatric Refractive Error 
Profile survey, employed by Walline et al., will be employed 
to assess and compare vision-specific quality of life of those 
children in the OK and the SV groups, both at the 12- and 
the 24-month follow-up visits.25,26 The survey was modified 
for both the OK and the SV groups and consists of 26 ques-
tions to which was added two additional questions:
27. The habitual handling of my contact lenses/glasses is 
normally done by my parents. 
28. I usually perform the handling of my contact lenses/
glasses.
All the questions have a stem of five possible responses: 
strongly disagree, disagree, neutral, agree and strongly agree. 
The surveys will be answered by the children, and parents 
will be asked not to participate. 
The same format was used for two further questions to be 
answered only by the parents: 
1. I think orthokeratology contact lenses/glasses are an 
excellent method of visual correction.
FIGURE 1
Contact lens fitting criteria. The colour image at the bottom shows 
a bull’s eye corneal topography pattern required for a clinically 
acceptable lens fit. VA, visual acuity.
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2. Once this study is finished, I intend to continue offe-
ring this method of visual correction to my child. 
Number of Lenses Required. The number of contact lenses 
required to achieve an optimum fit during the initial contact 
lens fitting procedure was recorded, together with the reasons 
for the implemented changes (i.e. flat fit). At the follow-up 
visits, the number of lenses required throughout the study 
and the reasons for each change (i.e., lost and broken lenses, 
or change in refraction) are also recorded. 
Adverse Events and Discontinuations. The classification 
of adverse events and discontinuations were adapted from 
Morgan et al.27 Adverse events were classified as “serious,” 
“significant,” or “non-significant” according to table 3.27,28 
Although table 3 shows most of the ocular adverse events 
that could occur as a result of contact lens and spectacle 
wear, all adverse events, even those not shown in table 3, were 
recorded in this study. For obscure adverse reactions, the opi-
nion of the ophthalmologist on duty at the clinic is sought 
and the condition treated in collaboration with the MCOS 
clinician. In all cases, an appropriate classification of the 
adverse reaction is obtained. Recurrences of the same adverse 
event(s) in the same or fellow eye at any of the subsequent 
follow-up visits were classified as separate events; bilateral 
events were counted as two separate events. The incidence 
rate of each adverse event was recorded as a percentage of 
eyes per annum.29 
In this study, “discontinuation” is defined as the cessation 
of lens wear for the remainder of the study. Discontinuation 
may occur as a result of: adverse events, ocular discomfort, 
visual problems, lack of motivation, failure to follow up 
instructions, unacceptable visual acuity and other logistic 
or personal reasons that may or may not have been directly 
related to lens wear. Temporary suspension of lens wear of 
up to 2 weeks was allowed (at the investigator’s discretion) 
should significant symptoms or slit-lamp findings occur. 
Although temporarily discontinued, subjects were exami-
ned at frequent intervals until the condition completely 
subsided, and attempts were made to limit the duration of 
the suspension period to as few days as possible. Some sub-
jects were discontinued from the study as a result of “lost 
to follow up”; defined as a situation whereby a subject did 
not turn up at the next scheduled follow-up visit (despite 
active efforts to encourage attendance). The incidence rate 
of discontinuations was recorded as a percentage of subjects 
per annum.29 
Data Collection and Masking  
Investigator CV-C was responsible for the data collection; 
investigator JS-R undertook all the data analysis without 
knowing the identity of the study groups. 
TABLE 3 
Classification of adverse events. The table has been adapted from Morgan et al.28   
Classification Serious Significant Non-significant
Symptomatology Symptomatic Commonly symptomatic Asymptomatic
Description
Condition
An adverse event that is of no imme-
diate clinical concern and that does 
not warrant discontinuation from 
lens wear
Asymptomatic infiltrates (AI)
Asymptomatic infiltrative keratitis 
(AIK)
Blinking disorders
Deep stromal opacities
Epithelial vacuoles
Localized allergic reaction
Cornel white lines
Corneal epithelial Iron lines
An adverse event of sufficient clinical 
concern to warrant clinical interven-
tion and perhaps temporary discon-
tinuation from lens wear
3 and 9 o’clock staining
Disorders of the eyelids and lashes 
(e.g. blepharitis, meibomitis, hor-
deolum)
Conjunctival epithelial flaps 
Conjunctivitis
Contact-lens-induced acute red
eye (CLARE)
Contact-lens-induced papillary
conjunctivitis (CLPC)
Contact-lens-induced peripheral
ulcer (CLPU)
Corneal scarring
Epithelial microcysts
Epithelial arcuate lesion
Infiltrative keratitis (IK)
Keratoconjunctivitis
Ptosis
Vascularized limbal keratitis
Corneal abrasion requiring no medi-
cal intervention
An adverse event that produces or 
has the potential to produce signi-
ficant visual impairment and might 
warrant permanent
discontinuation from lens wear
Central corneal opacity
Corneal warpage
Epithelial wrinkling
Hypopyon
Microbial keratitis
Penetration of Bowman’s membrane
Persistent epithelial defect
Corneal abrasion requiring medical 
intervention
J Optom, Vol. 2, No. 4, October-December 2009
220   Myopia Control with Orthokeratology Contact Lenses in Spain (MCOS): Santodomingo-Rubido J et al.
  
Statistical Analysis
The goodness-of-fit Kolomogorov-Smirnov test was 
employed to assess whether or not baseline demographics, 
refractive and biometric data from both groups were sig-
nificantly different from one another, hypothesized on the 
basis of the assumption of a normal distribution. Normally 
and non-normally distributed data were expressed as mean ± 
standard deviation (SD) and median [quartiles], respectively. 
The differences between the two study groups in terms of 
baseline demographics, refractive and biometric data were 
analyzed using unpaired t-tests and Mann-Whitney U tests, 
depending on whether the results of the Kolomogorov-
Smirnov test demonstrated that the data were normally 
distributed or not normally distributed, respectively. Data for 
the right eye was only used to avoid the confounding effect 
of using non-independent data from both eyes.30 The level of 
statistical significance was taken as 5%.
RESULTS
Sixty-nine subjects were recruited for the study between 
March 2007 and March 2008. Thirty-one children were 
prospectively allocated to OK and 30 to the SV correction 
modalities (Figure 2). Eight subjects could not be enrolled in 
the study because they failed to meet the inclusion criterion 
for refraction (Figure 2). A normal frequency distribution 
was found for all baseline demographics, refractive and bio-
metric data in both groups (P>0.05), except for visual acuity 
and the cylindrical refractive component (P<0.01). Thus, 
parametric and non-parametric statistics were employed 
accordingly to assess differences between groups at baseli-
ne. Both study groups were well matched at baseline as no 
significant differences were found between the two groups 
neither in demographics, nor in refractive nor in biometric 
data (Table 4). 
Of the 31 subjects that were assigned orthokeratolo-
gy contact lens wear at baseline, an optimum lens fit was 
obtained in 21 subjects with the first contact lens fitted in 
accordance with the Menicon Professional Easy Fit software. 
Ten subjects required a total of 35 adjustments to attain an 
optimum lens fit. Of these, 5 subjects required more than 
2 contact lens fit changes per eye; 5 subjects required just 
1 change each; 2 subjects required 1 change per eye each; 
2 subjects required 2 changes per eye each; and 3 subjects 
required 3 changes each. The reasons for the changes were: 
undercorrection (13), lens decentration (12) and central 
island (10). Across the whole group, an average of 1.6 lenses 
per eye were required to attain an optimum fit. Two subjects 
broke their lenses (2) and one subject lost one lens in the 
interim between initial contact lens fitting and final enrol-
ment in the study (Figure 1).
None of the subjects showed corneal staining and no adver-
se events were found in any of the two groups at baseline.
DISCUSSION
To the authors’ knowledge, the MCOS study is the first 
prospective clinical trial to assess the efficacy and safety of 
OK lens wear for myopia progression vs. a group of SV spec-
tacle lens wearers. Subjects and parents engaged enthusiasti-
cally in the study and responded well to initial introduction 
of the study design and protocol. The number of contact 
lenses required to achieve an optimum fit were either lower 
than31 or similar to32 those reported in previous studies. 
For the present study (MCOS), the subjects’ baseline 
refractive and biometric data were markedly similar to those 
from other studies assessing the effects of orthokeratology 
contact lens wear on myopia progression in children.15,16 
Also, similar age groups and male/female ratios were emplo-
yed in MCOS compared to a previous study;15 another study 
FIGURE 2
Subjects recruited for the study.
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employed an older group and a higher percentage of female 
subjects.16
Although we are fully aware of the advantages of random 
allocation, to our knowledge no previous study on the effects 
of orthokeratology contact lens wear on myopia progression 
has used a randomized design. Subjects were not randomized 
into the two modalities of visual correction in MCOS, but both 
study groups were well matched, as shown by the similarity 
between the baseline demographics, refractive and biometric 
data collected in the two groups. Also, all subjects from both 
study groups in MCOS were monitored over the same time 
period. Previous studies have used historical prospective con-
trol groups that had not been monitored over the same time 
period; the latter feature might introduce a higher bias than that 
due to MCOS’s design (e.g. it is possible that children from 
the historical control groups were monitored during times of 
different environmental exposure, such as greater levels of close 
work, compared to the experimental groups). Furthermore, the 
advantage of MCOS’s approach is that it is apposite to actual 
clinical practice, where practitioners provide various options of 
visual correction and parents opt for a particular option with the 
child’s approval. 
A limitation of this study is that, in terms of statistical 
power, the sample size employed is theoretically too small 
to detect the absolute incidence rates of adverse events and 
discontinuations for each of the two modalities of visual 
correction under investigation. However, we envisage 
that it might be sufficiently powered to detect differences 
in incidence rate between the two groups, as previous 
studies with samples sizes similar to those used in the 
present study have effectively demonstrated differences in 
incidence rate for different contact lens types and wearing 
regimes.27,29
The primary outcome measure of this study is, however, 
to compare in white European myopic children axial length 
growth following OK and SV lens wear over a 2-year period. 
In this respect, the comparison of axial growth between the two 
groups is optimized by the use of non-contact partial coherence 
interferometry, which has a resolution that is an order of magni-
tude better than that of the 10 Hz ultrasound technique.18 
Since the start of the MCOS, the importance of peripheral 
imagery in the etiology of myopia has been acknowledged 
both in animal and in human studies.33-35 Consequently, as an 
adjunct to the present study, peripheral axial length measures 
in the horizontal plane (using partial coherence interferome-
try) will be recorded at the 24-month follow-up visit for both 
study groups, at successive eccentricities at successive eccentri-
cities from from 10º to 30º temporally and nasally.36
Another constraint of the MCOS study is that the 
investigator collecting clinical data (CV-C) was not masked 
with respect to the mode of visual correction. Full masking 
of data collection in clinical trials such as MCOS presents 
difficulties, in that the identity of the subject's group can 
be revealed by a variety of clinical observations such as, for 
example, limbal or conjunctival staining or corneal topogra-
phy measurements. Nevertheless, the investigator collecting 
data was fully aware of the need to disregard where feasible 
the identity of the subject’s group. Furthermore, data analysis 
was undertaken by an investigator (JS-R) who was masked 
with regard to the identity of the study groups. 
Although some limitations in the MCOS study have 
been identified, the study offers a number of notable featu-
res: a prospective design; well-matched samples and high-
resolution ocular biometry measures, which collectively 
should elucidate whether or not OK contact lens wear is a 
feasible and safe method for myopia progression control. 
TABLE 4 
Baseline subjects’ demographics, and refractive and biometric data. Normally and non-normally distributed data were expressed as mean ± 
standard deviation (SD) and median [quartiles], respectively. “P-value” refers to the statistical P-value; “p-value (units)” refers to the rate of 
peripheral corneal flattening or steepening  
Subjects’ demographics OK SV P-value
Age (years) 9.6±1.6 9.9±1.9 0.76
Male/female ratio 15/16 15/15 -
Best corrected VA (decimal) 1.00 [1.00 – 1.20]  1.00 [1.0 – 1.15] 
 (0.00 logMAR or 20/20 Snellen) (0.00 logMAR or 20/20 Snellen) 0.25
Refractive components   
  Sphere (D) -2.15±1.12 -2.08±1.23 0.79
  Cylinder (mm) -0.25 [-0.50 – 0.00] 0.00 [-0.50 – 0.00] 0.96
Biometric components   
  Axial length (mm) 24.40±0.81 24.22±0.91 0.40
  Anterior Chamber Depth (mm) 3.63±0.55 3.76±0.38 0.28
  Posterior Segment Depth (mm) 20.76±0.90 20.46±0.90 0.17
  Flat meridian (D) 42.97±1.65 43.41±1.56 0.36
  Steep meridian (D) 43.69±1.46 44.01±1.77 0.50
  Rate of peripheral corneal flattening  
  or steepening (p-value) 0.69±0.10 0.72±0.08 0.16
OK: Orthokeratology; SV: single-vision spectacles; VA: visual acuity; D: diopters.
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